Tumor necrosis has been associated with a poor outcome in breast carcinoma [34] and usually generates cytokine-like IL-1 and HMGB1 with a role of promoting inflammatory response and neoangiogenesis [35]. The gene discussed is HMGB1; the disease is breast carcinoma.